Anti‐seizure medications in patients with post‐stroke epilepsy: A survival analysis study
In this population-based cohort study, ASM use in patients with PSE was associated with a significantly reduced risk of all-cause mortality compared to non-use. These findings support the hypothesis that ASM treatment might be associated with positive effect in this high-risk population.
Authors
- Pietro Ferrara (ORCID: https://orcid.org/0000-0002-0349-3221)
- Davide Rozza (ORCID: https://orcid.org/0000-0003-2648-742X)
- Carla Fornari (ORCID: https://orcid.org/0000-0002-9609-9556)
- Paolo Angelo Cortesi (ORCID: https://orcid.org/0000-0001-5241-4473)
- LG Mantovani (ORCID: https://orcid.org/0000-0003-3866-8199)
- Giampiero Mazzaglia (ORCID: https://orcid.org/0000-0003-4933-2148)
- Giacomo Crotti (ORCID: https://orcid.org/0000-0002-1053-1046)
- Ippazio Cosimo Antonazzo (ORCID: https://orcid.org/0000-0001-8046-4574)
- Alberto Zucchi (ORCID: https://orcid.org/0000-0002-1522-4029)
- Gabriele Buongarzone
Institutions
- University of Bergamo (IT)
- University of Ferrara (IT)
- Health Protection Agency (MV)
- IRCCS Istituto Auxologico Italiano (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Milano-Bicocca (IT)
Publication Details
- Journal
- Epilepsia
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1111/epi.18706
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00